Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 936,209 $ 2,645,852
Accounts receivable, net 0 750
Grant receivable 145,336 186,668
Prepaid expenses 465,196 213,283
Total current assets 1,546,741 3,046,553
Property and equipment, net 133,442 148,300
Right to use assets 514,324 458,707
Other assets:    
Patents, net 12,858 13,736
Intellectual property, net 188,640 224,010
Deposits, long term 44,520 41,936
Total other assets 246,018 279,682
Total assets 2,440,525 3,933,242
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $603,561 and $391,209, respectively 2,071,630 2,027,380
Deferred revenue, short term 74,935 134,924
Deferred revenue-grant 370,023 0
Lease liability, short term 103,098 76,977
Notes payable 21,480 21,480
Notes payable, related parties 290,110 290,110
PPP loan, short term 15,445 0
Total current liabilities 2,946,721 2,550,871
Long term liabilities:    
PPP loan, long term 12,555 0
EIDL loan, long term 74,300 0
Royalty obligation, net of discount of $6,453,436 and $6,812,318, related parties 2,268,664 1,909,782
Lease liability, long term 463,372 428,162
Deferred revenue, long term 78,402 103,313
Total liabilities 5,844,014 4,992,128
Commitments and contingencies 0 0
Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, 5,410,506 and 5,326,852 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 5,411 5,327
Common stock subscribed 100,000 100,000
Additional paid in capital 60,368,581 60,111,429
Accumulated deficit (63,785,740) (61,216,080)
Total deficit attributable to BioCorRx , Inc. (3,290,132) (977,708)
Non-controlling interest (113,357) (81,178)
Total deficit (3,403,489) (1,058,886)
Total liabilities and deficit 2,440,525 3,933,242
Convertible Series A Preferred Stock [Member]    
Deficit:    
Preferred stock value 16,000 16,000
Convertible Series B Preferred Stock [Member]    
Deficit:    
Preferred stock value $ 5,616 $ 5,616